Contact | Search on Europa  

Infectious Diseases print icon
Graphic element
   
Graphic element General information
  RTD Infectious Diseases Unit
  Developing countries
  EDCTP
   
Graphic element Projects
  About FP6 Funding
  FP6 projects
  About FP5 Funding
  FP5 projects
   
   
Graphic element Addressed Diseases
  HIV/AIDS
- News
  Malaria
- News
  Tuberculosis
   
Graphic element Calls for proposals
  FP7 Calls
   
Graphic element Contact corner
  Unit
  Scientific officers
  Subscribe to our mailing list
   
 
HIV/AIDS, Malaria and Tuberculosis

BIG EVENT coming

Conference Research on HIV/AIDS, Malaria and Tuberculosis, challenges for the future
Brussels, 13-14 November 2008 Charlemagne building.

The European Commission – DG Research proposes a conference bringing together top scientists, policymakers & funding agencies, including significant participation from disease-endemic countries, to consider strategies for the future of poverty related infectious diseases research. The Conference will be also include an important reflection on the results obtained with FP6 and consider possible future lines of research on HIV, malaria and tuberculosis in FP7 and beyond.

More information (PDF - 15 KB)

New















Paper version available soon

Influenza Research:
EU FUNDED PROJECTS 2001-2007

Pandemic influenza has become a paradigm of the potential health threat that emerging infectious diseases pose to the world. Today, we could not be further from the optimism of the 1960s and 1970s, when statements like ‘the war against infectious diseases has been won’ abounded. The ‘Spanish Flu’ pandemic of 1918 to 1919 remains one of the most deadly infectious diseases of all time, and the recent spread of the highly pathogenic avian influenza virus H5N1 is just the most recent example of the continued threat of emerging zoonoses. Against this background the European Commission’s Seventh Research Framework Programme (FP7, 2007-2013) has established for the first time a new dedicated activity — ‘Emerging Infectious Epidemics’ — and the Council Decision for FP7’s Specific Programme ‘Cooperation’1 explicitly mentions highly pathogenic influenza in the description of this activity.

The new mandate to build a coherent strategy in this research area is also an opportunity to take stock of past and ongoing EU-funded activities in influenza research. As with previous disease outbreaks, such as BSE (bovine spongiform encephalopathy) and SARS (Sudden Acute Respiratory Syndrome), the Commission has been able to respond rapidly to the spread of bird flu and human sporadic cases of H5N1 with a EUR 28 million dedicated call for proposals, launched in late 2005. The present publication also demonstrates the longer-term track record of Framework Programme funding in this field. Read more... [8MB PDF]


Graphic element

Infectious Diseases

The global emergency caused by HIV/AIDS, malaria and tuberculosis requires new approaches to confront these three major poverty-related diseases. In response to this emergency, the European Commission provides a broad comprehensive approach in a wide range of policy areas, including trade, development and research. For research, the overall strategy is to develop new drugs, vaccines and other effective interventions through two mechanisms:

  • Support of research projects of promising new candidates through pre-clinical and early human testing and;
  • Establishment of a programme to support phases II and III clinical trials in Africa. The Sixth Framework Programme - FP6 (2002-2006) allocates a total of € 400 million to HIV/AIDS, malaria and tuberculosis of which 200 Million for EDCTP (European Developing Countries Clinical Trials Partnership

Highlights

AllomicrovacGraphic elementAllomicrovac

A combined microbicidal-immunizing strategy against SIV and HIV infection more
CILMALVAC Graphic elementCILMALVAC

The Tetrahymena system as an innovative approach to malaria antigene expression more
DETECTHIV Graphic elementDETECTHIV

Sensitive Nanoparticle Assay For the Detection of HIV more
EPIVAC Graphic elementEPIVAC

Development of a multi-step Improved Epidermis Specific Vaccine Candidate against HIV/AIDS more
EUROPRISE Graphic elementEUROPRISE

European Vaccines and Microbicides Enterprise more
GISHEAL Graphic elementGISHEAL

Genetic and Immunological Studies of European and African HIV-1+ Long Term Non-Progressors more
HIV PI resistance Graphic elementHIV PI resistance

HIV protease inhibitor resistance by enzyme- substrate coevolution more
HUMALMABGraphic elementHUMALMAB

Human monoclonal antibodies as tools for malaria research and therapy >>more
Immuno VacTB Graphic elementImmuno VacTB

A new approach for developing a less Immunosuppressive Vaccine for Tuberculosis more
INNOVAC Graphic elementINNOVAC

Highly Innovative Strategies for Vaccination to Poverty Related Diseases more

Graphic element

Scheme of the Research process through the different framework activities

 
Scheme of the Research process through the different framework activities

 

Graphic element
    Graphic element